Network systems biology for drug discovery

Clinical Pharmacology and Therapeutics

Volumn 88, Issue 1, 2010, Pages 120-125

  Arrell, D K ^a   Terzic, A ^a  

^a Marriott Heart Disease Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

BIOINFORMATICS; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; MATHEMATICAL MODEL; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY;

COMPUTATIONAL BIOLOGY; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; GENE REGULATORY NETWORKS; MODELS, STATISTICAL; PROTEINS; RECEPTORS, DRUG; SYSTEMS BIOLOGY;

EID: 77953811662     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.91     Document Type: Review

References (38)

1. von Bertalanfy, L. An outline of general system theory. Br. J. Philos. Sci. 1, 139-164 (1950).
2. Hodgkin, A.L. & Huxley, A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. (Lond.) 117, 500-544 (1952).
3. Noble, D. Cardiac action and pacemaker potentials based on the Hodgkin-Huxley equations. Nature 188, 495-497 (1960)
4. von Bertalanfy, L. General System Theory: Foundations, Development, Applications (George Braziller, New york, 1968)
5. Mesarovic, M.D. Systems Theory and Biology (Springer, New york, 1968)
6. Savageau, M.A. Biochemical Systems Analysis: A Study of Function and Design in Molecular Biology (Addison-Wesley, Reading, MA, 1976).
7. Weston, A.D. & Hood, L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J. Proteome Res. 3, 179-196 (2004).
8. Hood, L. & Perlmutter, R.M. The impact of systems approaches on biological problems in drug discovery. Nat. Biotechnol. 22, 1215-1217 (2004).
9. Kohl, P. & Noble, D. Systems biology and the virtual physiological human. Mol. Syst. Biol. 5, 292 (2009).
10. Silver, P.A. & Way, J.C. Molecular systems biology in drug development. Clin. Pharmacol. Ther. 82, 586-590 (2007).
11. Arrell, D.K., Zlatkovic, J., Kane, G.C., yamada, S. & Terzic, A. ATP-sensitive K+ channel knockout induces cardiac proteome remodeling predictive of heart disease susceptibility. J. Proteome Res. 8, 4823-4834 (2009).
12. Nelson, T., Behfar, A. & Terzic, A. Stem cells: biologics for regeneration. Clin. Pharmacol. Ther. 84, 620-623 (2008).
13. Bartunek, J., Sherman, W., Vanderheyden, M., Fernandez-Aviles, F., Wijns, W. & Terzic, A. Delivery of biologics in cardiovascular regenerative medicine. Clin. Pharmacol. Ther. 85, 548-552 (2009).
14. Waldman, S.A. & Terzic, A. Therapeutic targeting: a crucible for individualized medicine. Clin. Pharmacol. Ther. 83, 651-654 (2008).
15. Barabasi, A.L. & Albert, R. Emergence of scaling in random networks. Science 286, 509-512 (1999).
16. Barabási, A.L. Scale-free networks: a decade and beyond. Science 325, 412-413 (2009).
17. Barabási, A.L. & Oltvai, Z.N. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 5, 101-113 (2004).
18. Merico, D., Gfeller, D. & Bader, G.D. How to visually interpret biological data using networks. Nat. Biotechnol. 27, 921-924 (2009).
19. Khalil, I., Brewer, M.A., Neyarapally, T. & Runowicz, C.D. The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer. Gynecol. Oncol. 116, 282-285 (2010).
20. Sauer, U., Heinemann, M. & Zamboni, N. Genetics. Getting closer to the whole picture. Science 316, 550-551 (2007).
21. Alekseev, A.E., Hodgson, D.M., Karger, A.B., Park, S., Zingman, L.V. & Terzic, A. ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart. J. Mol. Cell. Cardiol. 38, 895-905 (2005).
22. Arrell, D.K., Niederländer, N.J., Faustino, R.S., Behfar, A. & Terzic, A. Cardioinductive network guiding stem cell diferentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells 26, 387-400 (2008).
23. Albert, R., Jeong, H. & Barabasi, A.L. Error and attack tolerance of complex networks. Nature 406, 378-382 (2000).
24. Hwang, W.C., Zhang, A. & Ramanathan, M. Identifcation of information fow-modulating drug targets: a novel bridging paradigm for drug discovery. Clin. Pharmacol. Ther. 84, 563-572 (2008).
25. Palumbo, M.C., Colosimo, A., Giuliani, A. & Farina, L. Functional essentiality from topology features in metabolic networks: a case study in yeast. FEBS Lett. 579, 4642-4646 (2005).
26. Zhong, Q. et al. Edgetic perturbation models of human inherited disorders. Mol. Syst. Biol. 5, 321 (2009).
27. Pawson, T. & Linding, R. Network medicine. FEBS Lett. 582, 1266-1270 (2008).
28. Schoeberl, B. et al. Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis. Sci. Signal. 2, ra31 (2009).
29. Ishii, N. et al. Multiple high-throughput analyses monitor the response of E. coli to perturbations. Science 316, 593-597 (2007).
30. Lu, R. et al. Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 462, 358-362 (2009)
31. yildirim, M.A., Goh, K.I., Cusick, M.E., Barabási, A.L. & Vidal, M. Drug-target network. Nat. Biotechnol. 25, 1119-1126 (2007).
32. Chiang, A.P. & Butte, A.J. Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin. Pharmacol. Ther. 86, 507-510 (2009).
33. Keiser, M.J., Roth, B.L., Armbruster, B.N., Ernsberger, P., Irwin, J.J. & Shoichet, B.K. Relating protein pharmacology by ligand chemistry. Nat. Biotechnol. 25, 197-206 (2007).
34. Hopkins, A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682-690 (2008).
35. Keiser, M.J. et al. Predicting new molecular targets for known drugs. Nature 462, 175-181 (2009).
36. Paolini, G.V., Shapland, R.H., van Hoorn, W.P., Mason, J.S. & Hopkins, A.L. Global mapping of pharmacological space. Nat. Biotechnol. 24, 805-815 (2006).
37. Arrell, D.K., Niederländer, N.J., Perez-Terzic, C., Chung, S., Behfar, A. & Terzic, A. Pharmacoproteomics: advancing the efcacy and safety of regenerative therapeutics. Clin. Pharmacol. Ther. 82, 316-319 (2007).
38. Faustino, R.S. & Terzic, A. Bioinformatic networks: molecular reticles for pinpointing pharmacological target selection. Clin. Pharmacol. Ther. 84, 543-545 (2008).